Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

ERS Technical Standard on Bronchial Challenge Testing: Pathophysiology and Methodology of Indirect Airway Challenge Testing.

Hallstrand TS, Leuppi JD, Joos G, Hall GL, Carlsen KH, Kaminsky DA, Coates AL, Cockcroft DW, Culver BH, Diamant Z, Gauvreau GM, Horvath I, de Jongh FHC, Laube BL, Sterk PJ, Wanger J.

Eur Respir J. 2018 Oct 25. pii: 1801033. doi: 10.1183/13993003.01033-2018. [Epub ahead of print]

PMID:
30361249
2.

Characterizing Nebulizer Performance for Methacholine Challenge Tests.

Coates A, Culver B, Cockcroft D, Hallstrand T, Haynes J, Kaminsky D, MacIntyre N, Wanger J.

Am J Respir Crit Care Med. 2018 Oct 15;198(8):988-990. doi: 10.1164/rccm.201805-0942ED. No abstract available.

PMID:
30160985
3.

Reply to Johnson: Improve Pulmonary Function Test Reporting.

Culver BH, Graham BL, MacIntyre NR, McCormack M, Kaminsky DA, Coates AL, Weiner DJ, Rosenfeld M, Wanger J; ATS Committee on Proficiency Standards for Pulmonary Function Laboratories.

Am J Respir Crit Care Med. 2018 Jul 1;198(1):138-139. doi: 10.1164/rccm.201802-0280LE. No abstract available.

PMID:
29533673
4.

Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement.

Culver BH, Graham BL, Coates AL, Wanger J, Berry CE, Clarke PK, Hallstrand TS, Hankinson JL, Kaminsky DA, MacIntyre NR, McCormack MC, Rosenfeld M, Stanojevic S, Weiner DJ; ATS Committee on Proficiency Standards for Pulmonary Function Laboratories.

Am J Respir Crit Care Med. 2017 Dec 1;196(11):1463-1472. doi: 10.1164/rccm.201710-1981ST.

PMID:
29192835
5.

DLCO: adjust for lung volume, standardised reporting and interpretation.

Graham BL, Brusasco V, Burgos F, Cooper BG, Jensen R, Kendrick A, MacIntyre NR, Thompson BR, Wanger J.

Eur Respir J. 2017 Aug 24;50(2). pii: 1701144. doi: 10.1183/13993003.01144-2017. Print 2017 Aug. No abstract available.

PMID:
28838984
6.

ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests.

Coates AL, Wanger J, Cockcroft DW, Culver BH; Bronchoprovocation Testing Task Force: Kai-Håkon Carlsen, Diamant Z, Gauvreau G, Hall GL, Hallstrand TS, Horvath I, de Jongh FHC, Joos G, Kaminsky DA, Laube BL, Leuppi JD, Sterk PJ.

Eur Respir J. 2017 May 1;49(5). pii: 1601526. doi: 10.1183/13993003.01526-2016. Print 2017 May.

7.

2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung.

Graham BL, Brusasco V, Burgos F, Cooper BG, Jensen R, Kendrick A, MacIntyre NR, Thompson BR, Wanger J.

Eur Respir J. 2017 Jan 3;49(1). pii: 1600016. doi: 10.1183/13993003.00016-2016. Print 2017 Jan.

8.

Executive Summary: 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung.

Graham BL, Brusasco V, Burgos F, Cooper BG, Jensen R, Kendrick A, MacIntyre NR, Thompson BR, Wanger J.

Eur Respir J. 2017 Jan 3;49(1). pii: 16E0016. doi: 10.1183/13993003.E0016-2016. Print 2017 Jan.

9.

Quality Standards in Pulmonary Function Testing: Past, Present, Future.

Wanger JS, Culver BH.

Ann Am Thorac Soc. 2016 Sep;13(9):1435-6. doi: 10.1513/AnnalsATS.201604-300ED. No abstract available.

PMID:
27627467
10.

T-cell epitope strength in WAP-T mouse mammary carcinomas is an important determinant in PD1/PD-L1 immune checkpoint blockade therapy.

Bruns M, Wanger J, Schumacher U, Deppert W.

Oncotarget. 2016 Oct 4;7(40):64543-64559. doi: 10.18632/oncotarget.11620.

11.

FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis.

Raghu G, Scholand MB, de Andrade J, Lancaster L, Mageto Y, Goldin J, Brown KK, Flaherty KR, Wencel M, Wanger J, Neff T, Valone F, Stauffer J, Porter S.

Eur Respir J. 2016 May;47(5):1481-91. doi: 10.1183/13993003.01030-2015. Epub 2016 Mar 10.

12.

An inducible transgenic mouse breast cancer model for the analysis of tumor antigen specific CD8+ T-cell responses.

Bruns M, Wanger J, Utermöhlen O, Deppert W.

Oncotarget. 2015 Nov 17;6(36):38487-503. doi: 10.18632/oncotarget.5750.

13.

An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease.

Singh SJ, Puhan MA, Andrianopoulos V, Hernandes NA, Mitchell KE, Hill CJ, Lee AL, Camillo CA, Troosters T, Spruit MA, Carlin BW, Wanger J, Pepin V, Saey D, Pitta F, Kaminsky DA, McCormack MC, MacIntyre N, Culver BH, Sciurba FC, Revill SM, Delafosse V, Holland AE.

Eur Respir J. 2014 Dec;44(6):1447-78. doi: 10.1183/09031936.00150414. Epub 2014 Oct 30. Review.

14.

An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease.

Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, McCormack MC, Carlin BW, Sciurba FC, Pitta F, Wanger J, MacIntyre N, Kaminsky DA, Culver BH, Revill SM, Hernandes NA, Andrianopoulos V, Camillo CA, Mitchell KE, Lee AL, Hill CJ, Singh SJ.

Eur Respir J. 2014 Dec;44(6):1428-46. doi: 10.1183/09031936.00150314. Epub 2014 Oct 30. Review.

15.

Usability in an EMR: a long journey. Interview by Gabriel Perna.

Wanger J.

Healthc Inform. 2013 Jul-Aug;30(5):35-6. No abstract available.

PMID:
24027815
16.

Standardisation of lung function testing: the authors' replies to readers' comments.

Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten C, Gustafsson P, Jensen R, Macintyre N, McKay RT, Pedersen OF, Pellegrino R, Viegi G, Wanger J.

Eur Respir J. 2010 Dec;36(6):1496-8. doi: 10.1183/09031936.00130010. No abstract available.

17.

Definition of COPD: based on evidence or opinion?

Pellegrino R, Brusasco V, Viegi G, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, Macintyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J.

Eur Respir J. 2008 Mar;31(3):681-2. doi: 10.1183/09031936.00154307. No abstract available.

18.

Experience using centralized spirometry in the phase 2 randomized, placebo-controlled, double-blind trial of denufosol in patients with mild to moderate cystic fibrosis.

Goss CH, McKone EF, Mathews D, Kerr D, Wanger JS, Millard SP; Cystic Fibrosis Therapeutics Development Network.

J Cyst Fibros. 2008 Mar;7(2):147-53. Epub 2007 Aug 28.

19.

Interpretative strategies for lung function tests.

Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J.

Eur Respir J. 2005 Nov;26(5):948-68. No abstract available.

20.

Standardisation of the single-breath determination of carbon monoxide uptake in the lung.

Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R, Wanger J.

Eur Respir J. 2005 Oct;26(4):720-35. No abstract available.

21.

Standardisation of the measurement of lung volumes.

Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G.

Eur Respir J. 2005 Sep;26(3):511-22. Review. No abstract available.

22.

Standardisation of spirometry.

Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force.

Eur Respir J. 2005 Aug;26(2):319-38. No abstract available.

23.

General considerations for lung function testing.

Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force.

Eur Respir J. 2005 Jul;26(1):153-61. Review. No abstract available.

24.

Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies.

Kim KT, Kerwin E, Landwehr L, Bernstein JA, Bruner D, Harris D, Drda K, Wanger J, Wood CC; Pediatric Atrovent Nasal Spray Study Group.

Ann Allergy Asthma Immunol. 2005 Jan;94(1):73-9.

PMID:
15702820
25.

Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients.

Weisberg J, Wanger J, Olson J, Streit B, Fogarty C, Martin T, Casaburi R.

Chest. 2002 Apr;121(4):1070-8.

PMID:
11948034
26.

Single-breath carbon monoxide diffusing capacity.

Crapo RO, Jensen RL, Wanger JS.

Clin Chest Med. 2001 Dec;22(4):637-49. Review.

PMID:
11787656
27.

Airway responses to a diluent used in the methacholine challenge test.

Wanger JS, Ikle DN, Irvin CG.

Ann Allergy Asthma Immunol. 2001 Mar;86(3):277-82.

PMID:
11289324
28.

Correlation of cat-hair (Fel d1) prick skin test to airway response using a live-cat-room challenge model.

Wanger JS, Dockhorn RJ.

Allergy Asthma Proc. 1999 Nov-Dec;20(6):371-6.

PMID:
10624493
29.

Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.

Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ.

Am J Respir Crit Care Med. 2000 Jan;161(1):309-29. No abstract available.

PMID:
10619836
30.

Methacholine challenge testing: safety of low starting FEV1. Asthma Clinical Research Network (ACRN).

Martin RJ, Wanger JS, Irvin CG, Bucher Bartelson B, Cherniack RM.

Chest. 1997 Jul;112(1):53-6.

PMID:
9228357
31.

Quality assurance.

Wanger J.

Respir Care Clin N Am. 1997 Jun;3(2):273-89. Review.

PMID:
9390912
32.
33.

The effect of inspiratory maneuvers on expiratory flow rates in health and asthma: influence of lung elastic recoil.

Wanger JS, Ikle DN, Cherniack RM.

Am J Respir Crit Care Med. 1996 Apr;153(4 Pt 1):1302-8.

PMID:
8616558
34.

Comparability of pulmonary function results from 13 laboratories in a metropolitan area.

Wanger J, Irvin C.

Respir Care. 1991 Dec;36(12):1375-82.

PMID:
10145587
35.

Attenuation of the metabisulfite-induced bronchoconstrictive response by pretreatment with cromolyn.

McClellan MD, Wanger JS, Cherniack RM.

Chest. 1990 Apr;97(4):826-30.

PMID:
2108844
36.

Efficacy of a pulsed oxygen delivery device during exercise in patients with chronic respiratory disease.

Senn S, Wanger J, Fernandez E, Cherniack RM.

Chest. 1989 Sep;96(3):467-72.

PMID:
2766806
37.

Bronchodilator effects of low doses of oral theophylline and terbutaline in asthmatic subjects.

Deutsch RI, Tashkin DP, Simmons M, Calvarese B, Wanger J, Lee YE.

Ann Allergy. 1980 Sep;45(3):137-43.

PMID:
7416558

Supplemental Content

Loading ...
Support Center